Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey

dc.contributor.authorEser, Fatma
dc.contributor.authorGüner, Rahmet
dc.contributor.authorKesim Uçar, Şengül
dc.contributor.authorDüzenli, Tolga
dc.date.accessioned2023-05-30T10:27:57Z
dc.date.available2023-05-30T10:27:57Z
dc.date.issued2023en_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractIntroduction: We aimed to evaluate access to diagnosis, treatment and follow-up in patients with viral hepatitis during the COVID-19 pandemic. Methodology: Patients who started treatment for hepatitis B and hepatitis C were included in the study and analyzed in two periods: beforepandemic and during-pandemic. Indication for treatment and frequency of laboratory follow-up was obtained from hospital records. A telephone survey was administered to evaluate treatment access and compliance. Results: Four centers with 258 patients were included in the study. Of these 161 (62.4%) were male, median age was 50 years. The number of patients, admitted to outpatient clinics was 134647 in the before-pandemic period and 106548 in the during-pandemic period. Number of patients who started treatment for hepatitis B were significantly high during-pandemic period compared with before-pandemic (78 (0.07%); 73 (0.05%) respectively; p = 0.04). The number who received treatment for hepatitis C was similar in both periods: 43 (0.04%); 64 (0.05%), respectively (p = 0.25). Prophylactic treatment for hepatitis B, due to immunosuppressive agents was significantly higher in during-pandemic period (p = 0.001). In the laboratory follow-ups at 4th, 12th and 24th weeks of treatment, worse adherence was detected in during-pandemic (for all p < 0.05). Access to treatment and compliance of all patients was over 90% and did not differ in the two periods. Conclusions: During-pandemic, hepatitis patients' access to diagnosis, treatment initiation and follow-up had worsened in Turkey. The health policy implemented during the pandemic had a positive impact on patients' access to and compliance to treatment.
dc.description.provenanceSubmitted by Zeynep Umut NARİN (umutarslan@hitit.edu.tr) on 2023-05-30T10:27:43Z No. of bitstreams: 2 sengul-kesim-ucar2023.pdf: 1048609 bytes, checksum: 5c1a724909830b405fceb2932cea192a (MD5) license_rdf: 810 bytes, checksum: 73abee61e377f73f1d5fc0522cf9cde0 (MD5)en
dc.description.provenanceApproved for entry into archive by Zeynep Umut NARİN (umutarslan@hitit.edu.tr) on 2023-05-30T10:27:57Z (GMT) No. of bitstreams: 2 sengul-kesim-ucar2023.pdf: 1048609 bytes, checksum: 5c1a724909830b405fceb2932cea192a (MD5) license_rdf: 810 bytes, checksum: 73abee61e377f73f1d5fc0522cf9cde0 (MD5)en
dc.description.provenanceMade available in DSpace on 2023-05-30T10:27:57Z (GMT). No. of bitstreams: 2 sengul-kesim-ucar2023.pdf: 1048609 bytes, checksum: 5c1a724909830b405fceb2932cea192a (MD5) license_rdf: 810 bytes, checksum: 73abee61e377f73f1d5fc0522cf9cde0 (MD5) Previous issue date: 2023en
dc.identifier.citationEser, F., Güner, R., Gürbüz, Y., Akdoğan, M., Bilgiç, Z., Korkmaz, N., ... & Yamazhan, T. (2023). Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey. The Journal of Infection in Developing Countries, 17(04), 461-467.
dc.identifier.doi10.3855/jidc.17585
dc.identifier.endpage467en_US
dc.identifier.issn1972-2680
dc.identifier.issue4en_US
dc.identifier.pmid37159894
dc.identifier.scopusqualityQ2
dc.identifier.startpage461en_US
dc.identifier.urihttps://hdl.handle.net/11491/8477
dc.identifier.volume17en_US
dc.identifier.wosWOS:000992743400006
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherNLM (Medline)
dc.relation.ispartofJournal of infection in developing countries
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectHepatitis Ben_US
dc.subjectHepatitis Cen_US
dc.subjectCOVID-19en_US
dc.subjectAccessen_US
dc.subjectTreatmenten_US
dc.titleImpact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
sengul-kesim-ucar2023.pdf
Boyut:
1 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: